1. Home
  2. BHM vs NEPH Comparison

BHM vs NEPH Comparison

Compare BHM & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bluerock Homes Trust Inc.

BHM

Bluerock Homes Trust Inc.

N/A

Current Price

$8.36

Market Cap

34.4M

Sector

Real Estate

ML Signal

N/A

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$3.64

Market Cap

40.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHM
NEPH
Founded
2022
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.4M
40.1M
IPO Year
2022
2004

Fundamental Metrics

Financial Performance
Metric
BHM
NEPH
Price
$8.36
$3.64
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$15.00
$6.00
AVG Volume (30 Days)
7.5K
6.6K
Earning Date
01-01-0001
05-08-2026
Dividend Yield
4.54%
N/A
EPS Growth
N/A
1000.00
EPS
N/A
0.01
Revenue
$68,734,000.00
$18,789,000.00
Revenue This Year
N/A
$11.24
Revenue Next Year
N/A
$11.58
P/E Ratio
N/A
$377.00
Revenue Growth
36.88
32.67
52 Week Low
$8.05
$2.66
52 Week High
$14.45
$6.42

Technical Indicators

Market Signals
Indicator
BHM
NEPH
Relative Strength Index (RSI) 33.77 49.79
Support Level $8.05 $3.19
Resistance Level $9.60 $3.78
Average True Range (ATR) 0.28 0.24
MACD -0.02 0.00
Stochastic Oscillator 0.00 44.74

Price Performance

Historical Comparison
BHM
NEPH

About BHM Bluerock Homes Trust Inc.

Bluerock Homes Trust Inc owns and operates a portfolio of institutional residential properties including single-family homes, build-to-rent communities, and other residential communities located in attractive markets with a focus on the knowledge-economy and high-quality of life growth markets of the Sunbelt and Western United States. The company's principal objective is to generate attractive risk-adjusted returns on investments where it believes it can drive growth in funds from operations and net asset value by acquiring residential units, developing residential communities, and through value-add renovations. The company has two reportable segments, consisting of Residential Communities, which derives maximum revenue; and Scattered Single-family homes.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: